Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
Jingjing Cai, Meng Xu, Xiao‐Jing Zhang, et al.
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 14, Iss. 1, pp. 153-184
Open Access | Times Cited: 84

Showing 26-50 of 84 citing articles:

Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity
Masahide Hamaguchi, Takuro Okamura, Takuya Fukuda, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis
Xiao‐Jing Zhang, Zhi‐Gang She, Junyong Wang, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 624
Closed Access | Times Cited: 33
The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China
Fang Lei, Juan‐Juan Qin, Xiaohui Song, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Projection of global burden and risk factors for aortic aneurysm – timely warning for greater emphasis on managing blood pressure
Xuewei Huang, Zhouxiang Wang, Zhengjun Shen, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 553-564
Open Access | Times Cited: 26
Macrophage metabolism in nonalcoholic fatty liver disease
Wenhui Zhang, Ren Lang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Innate immunity and nonalcoholic fatty liver disease
Jannis Kountouras
Annals of Gastroenterology (2023)
Open Access | Times Cited: 15
Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice
Na Li, Chenhui Zhu, Rongzhan Fu, et al.
Phytomedicine (2023) Vol. 124, pp. 155287-155287
Closed Access | Times Cited: 14
Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases
Yufeng Hu, Wei Li, Xu Cheng, et al.
Circulation Research (2024) Vol. 135, Iss. 1, pp. 222-260
Closed Access | Times Cited: 5
Milk Fat Globule–Epidermal Growth Factor–Factor 8 Improves Hepatic Steatosis and Inflammation
Lei Zhang, Ruifeng Tian, Xinxin Yao, et al.
Hepatology (2020) Vol. 73, Iss. 2, pp. 586-605
Closed Access | Times Cited: 34
Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages
Bing Sun, Ranteng Zhang, Zicong Liang, et al.
International Immunopharmacology (2021) Vol. 94, pp. 107438-107438
Closed Access | Times Cited: 32
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease
Ke‐Qiong Deng, Xuewei Huang, Fang Lei, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 2, pp. C630-C639
Closed Access | Times Cited: 22
Noble Gases Therapy in Cardiocerebrovascular Diseases: The Novel Stars?
Jiongshan Zhang, Wei Liu, Mingmin Bi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
Kevan Josloff, Jacob Beiriger, Adnan Khan, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 419-419
Open Access | Times Cited: 20
RING finger protein 13 protects against nonalcoholic steatohepatitis by targeting STING-relayed signaling pathways
Zhibin Lin, Peijun Yang, Yufeng Hu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice
Hai‐Jian Sun, Jianxin Tan, Xiaodong Shan, et al.
Metabolism (2023) Vol. 145, pp. 155579-155579
Closed Access | Times Cited: 11
Global, Regional, and National Burden of Ischemic Heart Disease from 1990 to 2050:The Long-Term Trends and Risk Factors
Yuqing Mi, Wei Li, Yuzhuo Liu, et al.
(2025)
Closed Access
Rationale for choosing antihypertensive therapy in a patient with NAFLD and arterial hypertension
С. Н. Мехтиев, O. A. Mekhtiyeva, O. M. Berko
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 86-95
Closed Access
Allicin Improves Diet-Induced Nonalcoholic Steatohepatitis and Gut Microbiota Dysbiosis in Mice via the Involvement of the Circadian Clock Gene Rev-erbα
Yupei Deng, Yiyi Zhang, Jie Xiao, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
NAFLD as a continuous driver in the whole spectrum of vascular disease
Wei Li, Jiayi Liu, Jingjing Cai, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 163, pp. 118-132
Closed Access | Times Cited: 26
Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5′‐monophosphate‐activated protein kinase pathway and reshaping gut microbiota
Chao Han, Zongshuo Li, Ruiying Liu, et al.
Journal of the Science of Food and Agriculture (2023) Vol. 103, Iss. 15, pp. 7721-7738
Closed Access | Times Cited: 10
Recent updates on targeting the molecular mediators of NAFLD
Jia Wang, Lei Wang, Xiao‐Jing Zhang, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 1-2, pp. 101-124
Closed Access | Times Cited: 9
Identification of pyroptosis-related gene signature in nonalcoholic steatohepatitis
Fei Mao, E. Wang, Li Fu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation
Baiyin Zhong, Zhonghui Xie, Jianhong Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
The transcription factor zinc fingers and homeoboxes 2 alleviates NASH by transcriptional activation of phosphatase and tensin homolog
Yichao Zhao, Lingchen Gao, Chenglin Jiang, et al.
Hepatology (2021) Vol. 75, Iss. 4, pp. 939-954
Closed Access | Times Cited: 21

Scroll to top